Omeros Corporation - Common Stock (NQ:OMER)

18.61 +0.14 (+0.76%)

Delayed Quote Updated: 4:00 PM EDT, Oct 2, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Omeros Corporation - Common Stock

< Previous 1 2

...

6 7 8 9 10 11 12 13 Next >

INVESTIGATION REMINDER: The Schall Law Firm Announces it is Investigating Claims Against Omeros Corporation and Encourages Investors with Losses to Contact the Firm

October 05, 2021

From The Schall Law Firm

Via Business Wire

44 Biggest Movers From Yesterday ↗

October 05, 2021

Gainers Xenon Pharmaceuticals Inc. (NASDAQ: XENE) shares climbed 101.9% to close at $31.50 on Monday after the company announced its phase 2 study of XEN1101 for the treatment of...

Via Benzinga

The Daily Biotech Pulse: J&J Files For Booster Dose Authorization, Gemini Restructures, Strata Skin CFO Departs, Kaleido Reports Positive Readout ↗

October 05, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Oct. 4) Avadel Pharmaceuticals plc (...

Via Benzinga

INVESTIGATION ALERT: The Schall Law Firm Announces It Is Investigating Claims Against Omeros Corporation and Encourages Investors With Losses to Contact the Firm

October 04, 2021

From The Schall Law Firm

Via Business Wire

Mid-Afternoon Market Update: Dow Drops 375 Points; Elmira Savings Bank Shares Spike Higher ↗

October 04, 2021

Toward the end of trading Monday, the Dow traded down 1.09% to 33,951.17 while the NASDAQ fell 2.28% to 14,234.17. The S&P also fell, dropping 1.49% to 4,292.00. The U.S. has...

Via Benzinga

Topics Stocks

OMER INVESTOR ALERT: ROSEN, A TOP RANKED LAW FIRM, Encourages Omeros Corporation Investors with Losses to Inquire About Class Action Investigation – OMER

October 04, 2021

From Rosen Law Firm

Via Business Wire

12 Health Care Stocks Moving In Monday's Intraday Session ↗

October 04, 2021

Gainers Progenity (NASDAQ:PROG) stock moved upwards by 18.43% to $2.12 during Monday's regular session. Trading volume for this security as of 12:30 EST is 91.5...

Via Benzinga

Mid-Day Market Update: Nasdaq Down 2%; Xenon Pharmaceuticals Shares Jump ↗

October 04, 2021

Midway through trading Monday, the Dow traded down 1.02% to 33,976.93 while the NASDAQ fell 2.14% to 14,255.08. The S&P also fell, dropping 1.23% to 4,303.43. The U.S. has the...

Via Benzinga

Topics Stocks

30 Stocks Moving In Monday's Mid-Day Session ↗

October 04, 2021

Gainers Xenon Pharmaceuticals Inc. (NASDAQ: XENE) shares jumped 71.1% to $26.69 after the company announced its phase 2 study of XEN1101 for the treatment of epilepsy met all...

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For October 4, 2021 ↗

October 04, 2021

Upgrades According to Raymond James, the prior rating for Roper Technologies Inc (NYSE:

Via Benzinga

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

October 04, 2021

Gainers OpGen (NASDAQ:OPGN) shares moved upwards by 30.07% to $3.59 during Monday's pre-market session. The market value of their outstanding shares is at $137.3...

Via Benzinga

54 Biggest Movers From Friday ↗

October 04, 2021

Check out these big penny stock gainers and losers Losers Spire Global, Inc.. (NYSE: SPIR) shares fell 43.3% to close at $7.10 on Friday. Spire Global, Inc....

Via Benzinga

The Week Ahead In Biotech (Oct. 3-9): ChemoCentryx FDA Decision, Conference Presentations, IPOs And More ↗

October 03, 2021

Biotech stocks came under pressure in the week ending Oct. 1, dragged by broader market weakness and the selling of vaccine stocks. Positive tidings from Merck & Co...

Via Benzinga

Mid-Afternoon Market Update: Nasdaq Rises Over 100 Points; Biomerica Shares Spike Higher ↗

October 01, 2021

Toward the end of trading Friday, the Dow traded up 1.49% to 34,346.53 while the NASDAQ rose 0.75% to 14,556.92. The S&P also rose, gaining 1.18% to 4,358.52. The U.S. has the...

Via Benzinga

Topics Stocks

Attention Biotech Investors: Mark Your Calendar For October PDUFA Dates ↗

October 01, 2021

Following a mixed month for regulatory approvals, biotech investors now turn toward a month of plenty as far as Food and Drug Administration decisions are concerned. Four new...

Via Benzinga

Stocks Mixed as Investors Try to Brush Off Economic Anxieties ↗

October 01, 2021

The Dow Jones Industrial Average is up 204 points at midday, after trading sideways this morning as September's anxieties over inflation and slowing economic growth continue to grip Wall Street.

Via Talk Markets

Topics Stocks

12 Health Care Stocks Moving In Friday's Intraday Session ↗

October 01, 2021

Gainers Biomerica (NASDAQ:BMRA) stock moved upwards by 39.33% to $6.27 during Friday's regular session. As of 12:30 EST, Biomerica's stock is trading at a volume...

Via Benzinga

Mid-Day Market Update: Dow Surges 300 Points; Omeros Shares Plummet ↗

October 01, 2021

Midway through trading Friday, the Dow traded up 0.88% to 34,141.74 while the NASDAQ rose 0.12% to 14,465.49. The S&P also rose, gaining 0.58% to 4,332.44. The U.S. has the...

Via Benzinga

Topics Stocks

Here's Why Omeros Stock Is Tanking Today ↗

October 01, 2021

The narsoplimab program hasn't proceeded as swimmingly as investors thought.

Via The Motley Fool

Why Are Omeros Shares Plunging On Friday? ↗

October 01, 2021

The FDA has identified deficiencies regarding Omeros Corporation's (NASDAQ: OMER) marketing application of narsoplimab for hematopoietic stem cell transplant-associated...

Via Benzinga

Mid-Morning Market Update: Markets Mostly Higher; ISM Manufacturing Index Rises In September ↗

October 01, 2021

Following the market opening Friday, the Dow traded up 0.49% to 34,010.27 while the NASDAQ fell 0.23% to 14,415.00. The S&P also rose, gaining 0.16% to 4,314.50. The U.S. has...

Via Benzinga

Topics Stocks

Omeros Provides Regulatory Update on Biologics License Application for Narsoplimab in the Treatment of HSCT-TMA

October 01, 2021

From Omeros Corporation

Via Business Wire

Why Omeros Stock Is Plummeting This Week ↗

September 30, 2021

The biotech stock was part of a larger Wall Street sell-off.

Via The Motley Fool

Benzinga's Top Ratings Upgrades, Downgrades For September 27, 2021 ↗

September 27, 2021

Upgrades According to Roth Capital, the prior rating for Seelos Therapeutics Inc (NASDAQ:

Via Benzinga

Looking Into Omeros's Return On Capital Employed ↗

September 20, 2021

According to data from Benzinga Pro, during Q2, Omeros's (NASDAQ:OMER) reported sales totaled $28.82 million. Despite a 21.55% increase in earnings, the company posted a loss of $...

Via Benzinga

Omeros: Q2 Earnings Insights ↗

August 09, 2021

Shares of Omeros (NASDAQ:OMER) moved higher in after-market trading after the company reported Q2 results. Quarterly Results Earnings per share rose 24.59% year over year to...

Via Benzinga

Omeros Corporation Reports Second Quarter 2021 Financial Results

August 09, 2021

From Omeros Corporation

Via Business Wire

Omeros Corporation to Announce Second Quarter Financial Results on August 9, 2021

August 03, 2021

From Omeros Corporation

Via Business Wire

Return On Capital Employed Overview: Omeros ↗

June 24, 2021

Omeros (NASDAQ:OMER) reported Q1 sales of $21.06 million. Earnings fell to a loss of $30.61 million, resulting in a 9.47% decrease from last quarter. In Q4, Omeros brought in $10....

Via Benzinga

Earnings Scheduled For August 9, 2021 ↗

August 09, 2021

Companies Reporting Before The Bell • Privia Health Group (NASDAQ:PRVA) is projected to report quarterly loss at $1.57 per share on revenue of $215.17 million. •...

Via Benzinga

< Previous 1 2

...

6 7 8 9 10 11 12 13 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.